
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
<p>Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme</p>
Ping Sun, Yue Xiao, Qianqian Di, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 6673-6687
Open Access | Times Cited: 81
Ping Sun, Yue Xiao, Qianqian Di, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 6673-6687
Open Access | Times Cited: 81
Showing 26-50 of 81 citing articles:
Charge-switchable cell-penetrating peptides for rerouting nanoparticles to glioblastoma treatment
Maria Mendes, Sandra C. C. Nunes, Tânia Cova, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 241, pp. 113983-113983
Open Access | Times Cited: 8
Maria Mendes, Sandra C. C. Nunes, Tânia Cova, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 241, pp. 113983-113983
Open Access | Times Cited: 8
Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations
Matías Daniel Caverzán, Luis Exequiel Ibarra
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134777-134777
Closed Access | Times Cited: 8
Matías Daniel Caverzán, Luis Exequiel Ibarra
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134777-134777
Closed Access | Times Cited: 8
Progress of nanoparticle drug delivery system for the treatment of glioma
Guogang Lai, Hao Wu, Kaixia Yang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 7
Guogang Lai, Hao Wu, Kaixia Yang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 7
Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier
Karan Wadhwa, PAYAL CHAUHAN, Shobhit Kumar, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 877-897
Open Access | Times Cited: 6
Karan Wadhwa, PAYAL CHAUHAN, Shobhit Kumar, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 877-897
Open Access | Times Cited: 6
Development of Polymer-Based Nanoformulations for Glioblastoma Brain Cancer Therapy and Diagnosis: An Update
Bijuli Rabha, Kaushik Kumar Bharadwaj, Siddhartha Pati, et al.
Polymers (2021) Vol. 13, Iss. 23, pp. 4114-4114
Open Access | Times Cited: 38
Bijuli Rabha, Kaushik Kumar Bharadwaj, Siddhartha Pati, et al.
Polymers (2021) Vol. 13, Iss. 23, pp. 4114-4114
Open Access | Times Cited: 38
Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation
David J. Lundy, Helen Nguyễn, Patrick C.H. Hsieh
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 34
David J. Lundy, Helen Nguyễn, Patrick C.H. Hsieh
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 34
Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas
Jiwei Cui, Yuanxin Xu, Haiyan Tu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1100-1125
Open Access | Times Cited: 33
Jiwei Cui, Yuanxin Xu, Haiyan Tu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1100-1125
Open Access | Times Cited: 33
Soluplus® promotes efficient transport of meloxicam to the central nervous system via nasal administration
Bence Sipos, Zsolt Bella, Ilona Gróf, et al.
International Journal of Pharmaceutics (2023) Vol. 632, pp. 122594-122594
Open Access | Times Cited: 14
Bence Sipos, Zsolt Bella, Ilona Gróf, et al.
International Journal of Pharmaceutics (2023) Vol. 632, pp. 122594-122594
Open Access | Times Cited: 14
Advances in nanotechnology for the treatment of GBM
Dongyan Wei, Ni Zhang, Shuang Qu, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 13
Dongyan Wei, Ni Zhang, Shuang Qu, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 13
A scientometric analysis and up-to-date review of nano-based drug delivery systems in glioblastoma treatment
Xing Yang, Feroza Yasinjan, Mei Yang, et al.
Nano Today (2023) Vol. 52, pp. 101961-101961
Closed Access | Times Cited: 13
Xing Yang, Feroza Yasinjan, Mei Yang, et al.
Nano Today (2023) Vol. 52, pp. 101961-101961
Closed Access | Times Cited: 13
The Role of Graphene Oxide Nanocarriers in Treating Gliomas
Bin Wang, Hanfei Guo, Haiyang Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20
Bin Wang, Hanfei Guo, Haiyang Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20
Nanocarriers Call the Last Shot in the Treatment of Brain Cancers
Amin Mehrabian, Mohammad Mashreghi, Saba Dadpour, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 20
Amin Mehrabian, Mohammad Mashreghi, Saba Dadpour, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 20
A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas
Leonardo Delello Di Filippo, Suzana Gonçalves Carvalho, Jonatas Lobato Duarte, et al.
Materials Today Bio (2023) Vol. 20, pp. 100671-100671
Open Access | Times Cited: 12
Leonardo Delello Di Filippo, Suzana Gonçalves Carvalho, Jonatas Lobato Duarte, et al.
Materials Today Bio (2023) Vol. 20, pp. 100671-100671
Open Access | Times Cited: 12
Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport
Vincent Lenders, Xanthippi Koutsoumpou, Philana Phan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 14, pp. 4672-4724
Open Access | Times Cited: 12
Vincent Lenders, Xanthippi Koutsoumpou, Philana Phan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 14, pp. 4672-4724
Open Access | Times Cited: 12
Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier
Aadya Nayak, Neerada Meenakshi Warrier, Rachana Raman, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105980-105980
Open Access | Times Cited: 4
Aadya Nayak, Neerada Meenakshi Warrier, Rachana Raman, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105980-105980
Open Access | Times Cited: 4
Advanced nanomicelles for targeted glioblastoma multiforme therapy
P Chithra, Dhiraj Bhatia, Raghu Solanki
Biomaterials Advances (2025) Vol. 170, pp. 214221-214221
Closed Access
P Chithra, Dhiraj Bhatia, Raghu Solanki
Biomaterials Advances (2025) Vol. 170, pp. 214221-214221
Closed Access
Peptide‑based therapeutic strategies for glioma: current state and prospects
Yajing Mi, Pengtao Jiang, Jing Luan, et al.
Peptides (2025) Vol. 185, pp. 171354-171354
Closed Access
Yajing Mi, Pengtao Jiang, Jing Luan, et al.
Peptides (2025) Vol. 185, pp. 171354-171354
Closed Access
Interplay Between Diabetes, Obesity and Glioblastoma Multiforme, and the Role of Nanotechnology in Its Treatment
Sourav De, Sabyasachi Banerjee, Gourab Dey, et al.
Journal of Nanotheranostics (2025) Vol. 6, Iss. 1, pp. 7-7
Open Access
Sourav De, Sabyasachi Banerjee, Gourab Dey, et al.
Journal of Nanotheranostics (2025) Vol. 6, Iss. 1, pp. 7-7
Open Access
Constructed transferrin receptor-targeted liposome for the delivery of fluvoxamine to improve prognosis in a traumatic brain injury mouse model
Liang Mi, Jiangyuan Yuan, Yuxin Jiang, et al.
Drug Delivery (2025) Vol. 32, Iss. 1
Open Access
Liang Mi, Jiangyuan Yuan, Yuxin Jiang, et al.
Drug Delivery (2025) Vol. 32, Iss. 1
Open Access
Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities
Daniel E. Morales, Shaker A. Mousa
Heliyon (2022) Vol. 8, Iss. 5, pp. e09517-e09517
Open Access | Times Cited: 17
Daniel E. Morales, Shaker A. Mousa
Heliyon (2022) Vol. 8, Iss. 5, pp. e09517-e09517
Open Access | Times Cited: 17
Advances in active targeting of ligand-directed polymeric nanomicelles via exploiting overexpressed cellular receptors for precise nanomedicine
Mona M. Agwa, Rehab Elsayed Marzouk, Sally Sabra
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23520-23542
Open Access | Times Cited: 3
Mona M. Agwa, Rehab Elsayed Marzouk, Sally Sabra
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23520-23542
Open Access | Times Cited: 3
Critical Challenges of Intravenous Nanomaterials Crossing the Blood‐Brain Barrier: from Blood to Brain
Weikang Luo, Cong Chen, Xin Guo, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 3
Weikang Luo, Cong Chen, Xin Guo, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 3
Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis
Yuanke Li, Ruiying Liu, Zhen Zhao
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 109-109
Open Access
Yuanke Li, Ruiying Liu, Zhen Zhao
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 109-109
Open Access
A Novel Drug Delivery System Utilizing Nanoparticles to Treat Neurological Disorders
Maharudra Pratap Singh, Arshi Waseem, Vinod Kumar, et al.
(2025), pp. 413-430
Closed Access
Maharudra Pratap Singh, Arshi Waseem, Vinod Kumar, et al.
(2025), pp. 413-430
Closed Access
Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice
Jia Ouyang, Yu Jiang, Chao Deng, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 4105-4115
Open Access | Times Cited: 22
Jia Ouyang, Yu Jiang, Chao Deng, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 4105-4115
Open Access | Times Cited: 22